Online Formulary
Using the Formulary
Therapeutic Sections
1. Gastro-intestinal system
2. Cardiovascular system
3. Respiratory
4. Nervous system
5. Infection
6. Endocrine system
7. Genito-urinary system
8. Immune System
8. Malignant disease
9. Blood and blood-forming organs
9. Nutrition and metabolic disorders
10. Musculoskeletal system
11. Eye
12. Ear
12. Nose
12. Oropharynx
13. Skin
14. Vaccines
15. Anaesthesia
16. Emergency Treatment of Poisoning
Palliative Care
Wound management products
Stoma products
Continence products
Borderline substances
General recommendations and information
Shared Care
Using the Formulary
Therapeutic Sections
1. Gastro-intestinal system
2. Cardiovascular system
3. Respiratory
4. Nervous system
5. Infection
6. Endocrine system
6.1 Antidiuretic hormone disorders
6.2 Corticosteroid responsive conditions
6.3 Diabetes mellitus and hypoglycaemia
6.3.1 Diabetes mellitus, blood glucose lowering drugs
6.3.1.1 Alpha glucosidase inhibitors
6.3.1.2 Biguanides
6.3.1.3 Dipeptidylpeptidase-4 inhibitors (gliptins)
6.3.1.4 Glucagon-like peptide-1 receptor agonists
6.3.1.5 Meglitinides
6.3.1.6 Sodium glucose co-transporter 2 inhibitors
6.3.1.7 Sulfonylureas
6.3.1.8 Thiazolidinediones
6.3.2 Diabetes mellitus, insulins
6.3.3 Diabetes mellitus, diagnostic and monitoring devices
6.3.4 Hypoglycaemia
6.4 Disorders of bone metabolism
6.5 Dopamine responsive conditions
6.6 Gonadotrophin responsive conditions
6.7 Hypothalamic and anterior pituitary hormone related disorders
6.8 Sex hormone responsive conditions
6.9 Thyroid disorders
Local recommendations (Endocrine)
7. Genito-urinary system
8. Immune System
8. Malignant disease
9. Blood and blood-forming organs
9. Nutrition and metabolic disorders
10. Musculoskeletal system
11. Eye
12. Ear
12. Nose
12. Oropharynx
13. Skin
14. Vaccines
15. Anaesthesia
16. Emergency Treatment of Poisoning
Palliative Care
Wound management products
Stoma products
Continence products
Borderline substances
General recommendations and information
Shared Care
Search
Feedback
Drug Status Key
On Formulary
Specialist Initiation
Shared Care
Hospital Only
Not Recommended
Preferences
First Line
Second Line
Third Line
No Preference
6.3.1 Diabetes mellitus, blood glucose lowering drugs
6.3.1.1 Alpha glucosidase inhibitors
6.3.1.2 Biguanides
6.3.1.3 Dipeptidylpeptidase-4 inhibitors (gliptins)
6.3.1.4 Glucagon-like peptide-1 receptor agonists
6.3.1.5 Meglitinides
6.3.1.6 Sodium glucose co-transporter 2 inhibitors
6.3.1.7 Sulfonylureas
6.3.1.8 Thiazolidinediones